The past and future of 'reported outcomes' in studies on chemotherapy neuropathy.

about

The past and future of 'reported outcomes' in studies on chemotherapy neuropathy.

Item

http://www.wikidata.org/entity/Q47928562

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The past and future of 'reported outcomes' in studies on chemotherapy neuropathy.

@en

The past and future of 'reported outcomes' in studies on chemotherapy neuropathy.

@nl

type

Item

label

The past and future of 'reported outcomes' in studies on chemotherapy neuropathy.

@en

The past and future of 'reported outcomes' in studies on chemotherapy neuropathy.

@nl

prefLabel

The past and future of 'reported outcomes' in studies on chemotherapy neuropathy.

@en

The past and future of 'reported outcomes' in studies on chemotherapy neuropathy.

@nl

P1476

The past and future of 'reported outcomes' in studies on chemotherapy neuropathy.

@en

P2093

A S Beutler

http://www.w3.org/2001/XMLSchema#string

C L Loprinzi

http://www.w3.org/2001/XMLSchema#string

N Majithia

http://www.w3.org/2001/XMLSchema#string

P2860

Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy.

Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial.

Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trials.

Inhibition of fluorouracil-induced stomatitis by oral cryotherapy.

Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment.

Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02.

Clinical and genetic predictors of paclitaxel neurotoxicity based on patient- versus clinician-reported incidence and severity of neurotoxicity in the ICON7 trial.

Randomized trials with quality of life endpoints: are doctors' ratings of patients' physical symptoms interchangeable with patients' self-ratings?

P304

2631-2632

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1093/ANNONC/MDX520

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28950347

http://www.w3.org/2001/XMLSchema#string

P932

5834098

http://www.w3.org/2001/XMLSchema#string